CML with thrombocytosis on Gleevec 2.
AAA repair and AVR [**2114**] with porcine graft 4.
[**2124-1-21**] 04:51AM BLOOD WBC-13.3* RBC-2.52* Hgb-8.0* Hct-24.3* MCV-97 MCH-31.7 MCHC-32.8 RDW-16.8* Plt Ct-146* [**2124-1-20**] 04:15AM BLOOD Neuts-97* Bands-0 Lymphs-2* Monos-0 Eos-1 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2124-1-21**] 04:51AM BLOOD Plt Ct-146* [**2124-1-21**] 04:51AM BLOOD Glucose-108* UreaN-28* Creat-1.4* Na-144 K-4.0 Cl-112* HCO3-22 AnGap-14 [**2124-1-21**] 04:51AM BLOOD Calcium-7.2* Phos-4.4 Mg-1.7 [**2124-1-16**] 11:12AM BLOOD Type-MIX Rates-/24 pO2-39* pCO2-36 pH-7.40 calHCO3-23 Base XS--1 Intubat-NOT INTUBA  Brief Hospital Course: 79yoW with CML treated with Gleevec x1 year, presented to [**Hospital1 18**] with diarrhea and repeated mechanical falls, thought to be side effects of the Gleevec.
She was initially treated with a heparin gtt, with plans to restart coumadin; however, she became coagulopathic and developed mucosal bleeding.
Heparin was discontinued and coumadin never started due to continued epistaxis.
Pt was placed on levophed for blood pressure support, and oxygenation maintained by 100% NRB.
She also refused po nutrition and placement of an NGT for feeding purposes.
Social work and chaplain were consulted.
Gleevec had been held, antibiotics used, and she remained on high supplemental oxygen and levophed support.
Care was continued but the patient could refuse any further efforts at treatment.
Medications on Admission: ----  Discharge Medications: ----  Discharge Disposition: Expired  Discharge Diagnosis: ARDS- noncardiogenic pulmonary edema Chronic myelogenous leukemia- thrombocytosis paroxysmal atrial fibrillation s/p stroke   Discharge Condition: expired  Discharge Instructions: -----  Followup Instructions: -----
